<DOC>
	<DOCNO>NCT00564031</DOCNO>
	<brief_summary>Endothelial dysfunction resistance artery woman menopause important development high blood pressure cardiovascular disease</brief_summary>
	<brief_title>Hormonal Replacement Therapy Small Artery Function</brief_title>
	<detailed_description>We aim study effect different hormone replacement therapy ( HRT ) function morphology resistance artery , look mechanistic basis . We expect HRT estrogens combination MPA may benefit function resistance artery may preserve morphological integrity endothelial cell regulatory action cytoskeleton .</detailed_description>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<criteria>All woman amenorrheic least 1.5 year . Menopausal status confirm serum concentration follicular stimulate hormone ( FSH &gt; 34 IU/ml ) estradiol ( E2 &lt; 50 pmol/l ) . Cigarette smoker woman : Hypertension Diabetes mellitus Clinical manifestation arteriosclerosis ( coronary heart disease , peripheral artery disease , cerebrovascular disease ) Venous thromboembolic disease Liver disorder Unexplained vaginal bleeding ; Personal family history breast cancer exclude .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>hormone replacement therapy ; endothelial function ;</keyword>
</DOC>